TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31314753

Group type: COMPARATOR
Intervention: Weight-based dosing for diethylcarbamazine (DEC; 6 mg/kg) and ivermectin (IVM; 200 ug/kg)
Number of subjects: 26000

Group type: EXPERIMENTAL
Intervention: New dosing pole with a 6-tablet maximum for both DEC and IVM
Number of subjects: 26000
Study: 30400777

Group type: EXPERIMENTAL
Intervention: Imiquimod cream (5%)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Podophyllotoxin cream (0.15%)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccination
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control vaccination
Number of subjects: 500
Study: 26917051

Group type: EXPERIMENTAL
Intervention: Artesunate plus sulfadoxine-pyrimethamine (AS + SP)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Dihydroartemisinin-piperaquine
Number of subjects: 303
Study: 24355831

Group type: EXPERIMENTAL
Intervention: Operating table height at nipple level (Group N)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Operating table height at umbilicus level (Group U)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Operating table height at xiphoid process level (Group X)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Operating table height at lowest rib margin (Group R)
Number of subjects: 160
Study: 22888768

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (treatment group)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo acupuncture (control group)
Number of subjects: 35
Study: 20394651

Group type: EXPERIMENTAL
Intervention: Azacitidine (75 mg/m2/day SC for 7 days every 28 days)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Conventional care regimens (CCR) including low-dose ara-C, BSC, or intensive chemotherapy
Number of subjects: 325
Study: 18759641

Group type: EXPERIMENTAL
Intervention: Risperidone (mean dose = 3.4 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Olanzapine (mean dose = 14.0 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quetiapine (mean dose = 611 mg)
Number of subjects: 30
Study: 15856037

Group type: COMPARATOR
Intervention: Epirubicin, cisplatin and infused 5FU (ECF)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 5FU, etoposide and leucovorin (FELV)
Number of subjects: 54
Study: 12209270

Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NPPV)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Invasive mechanical ventilation
Number of subjects: 48
Study: 10478770

Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability assessment
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Interexaminer reliability assessment
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Second examination
Number of subjects: 18
Study: 8941061

Group type: EXPERIMENTAL
Intervention: Four-pellet system containing 174 mg NET
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Five-pellet system containing 266.5 mg NET
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 39
Study: 1746792

Group type: EXPERIMENTAL
Intervention: Cefmetazole
Number of subjects: 138

Group type: COMPARATOR
Intervention: Cefoperazone
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 138

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 138

Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 138
Study: 2995463

Group type: EXPERIMENTAL
Intervention: Triple antibiotic ointment (bacitracin, polysporin, neomycin) applied thrice daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Triple antibiotic ointment
Number of subjects: 59
Study: 30660559

Group type: EXPERIMENTAL
Intervention: Isokinetic resistance training and eccentric overload (ISO/ECC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional resistance training (TRAD)
Number of subjects: 22
Study: 29703470

Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg BID
Number of subjects: 574

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 574
Study: 27893676

Group type: COMPARATOR
Intervention: Paclitaxel (175mg/m2) alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination therapy of paclitaxel and Avastin (5 mg/kg)
Number of subjects: 24
Study: 25300112

Group type: EXPERIMENTAL
Intervention: Vitamin-mineral complex (VMC) with additional intake of vitamins C and E (100-120% RDA), beta-carotene (40% RDA), nicotinamide (38% RDA), pantothenic acid and biotin (60% RDA), vitamins B12, B2 and folic acid (75-83% RDA), vitamins B1 and B6 (160-300% RDA), zinc (100% RDA), chromium (400% RDA), magnesium (17.7% RDA), and potassium (9.4% RDA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Low-calorie diet (1600 kcal/day)
Number of subjects: 120
Study: 22755281

Group type: EXPERIMENTAL
Intervention: External fixation with distraction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plaster of Paris cast
Number of subjects: 60
Study: 20944078

Group type: EXPERIMENTAL
Intervention: Conservative management
Number of subjects: 14302

Group type: COMPARATOR
Intervention: Radical prostatectomy
Number of subjects: 14302
Study: 21328517

Group type: EXPERIMENTAL
Intervention: Balaglitazone 10 mg
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Balaglitazone 20 mg
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg
Number of subjects: 409
Study: 15766816

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300-mg load followed by 75 mg/day) plus aspirin
Number of subjects: 12562

Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 12562
Study: 12779109

Group type: EXPERIMENTAL
Intervention: Ketamine (10 mg/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ketamine (10 mg/kg) + Promethazine (1.1 mg/kg)
Number of subjects: 22
Study: 9866432

Group type: EXPERIMENTAL
Intervention: Endocarditis prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perioperative anticoagulation in patients with mechanical heart valves
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucose control in diabetic patients undergoing surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of beta-blockers to prevent postoperative cardiac complications
Number of subjects: 0
Study: 8010474

Group type: EXPERIMENTAL
Intervention: Ketorolac infusion
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Ketorolac bolus
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Ketorolac infusion and bolus
Number of subjects: 207
Study: 2688532

Group type: EXPERIMENTAL
Intervention: iopromide 370
Number of subjects: 20

Group type: COMPARATOR
Intervention: ioxaglate 320
Number of subjects: 20
Study: 31944878

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) with fixed appliance
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (fixed appliance only)
Number of subjects: 89
Study: 29779564

Group type: EXPERIMENTAL
Intervention: 3.5-hour alertness management training followed by a two-month consultation period and motivational self-evaluation tasks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual statutory occupational health care services (Control)
Number of subjects: 53
Study: 28157112

Group type: EXPERIMENTAL
Intervention: Dual-mode stimulation (10Hz rTMS at 90% resting motor threshold, 1,000 pulses for 20 minutes + cathodal tDCS at 2mA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Single stimulation (10Hz rTMS without tDCS)
Number of subjects: 30
Study: 28316664

Group type: EXPERIMENTAL
Intervention: Neurofeedback therapy (20 sessions of 40 minutes each, 3 sessions per week)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 8
Study: 23966698

Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS) with PPC preceding M1 TMS by 5 ms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS) with PPC following M1 TMS by 5 ms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rotating the stimulating coil in M1 during the PAS protocol
Number of subjects: 0
Study: 20371017

Group type: EXPERIMENTAL
Intervention: Open surgical reconstruction without reinforcement
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Mini‐invasive procedure
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control Group (healthy subjects)
Number of subjects: 51
Study: 18925524

Group type: EXPERIMENTAL
Intervention: LMWH enoxaparin sodium (80 IU/kg) administered 10 minutes after the beginning of HD
Number of subjects: 18

Group type: COMPARATOR
Intervention: No LMWH administration during the first 20 minutes of HD
Number of subjects: 18
Study: 16612068

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 4 weeks
Number of subjects: 48
Study: 12553388

Group type: EXPERIMENTAL
Intervention: Cricoid yoke with surface area of 3 cm2 at forces of 10 N, 20 N, 30 N, and 40 N
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cricoid yoke with surface area of 10 cm2 at forces of 10 N, 20 N, 30 N, and 40 N
Number of subjects: 50
Study: 10778884

Group type: EXPERIMENTAL
Intervention: 50 mg DHEA administered orally at 0700 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (old-PL)
Number of subjects: 0
Study: 8793448

Group type: EXPERIMENTAL
Intervention: 2 mg nedocromil sodium
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Combination of 2 mg nedocromil sodium and 100 micrograms salbutamol
Number of subjects: 201
Study: 1333423

Group type: EXPERIMENTAL
Intervention: 100 mg/day itraconazole for 15 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: 500 mg/day griseofulvin for 15 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 100 mg/day itraconazole
Number of subjects: 40

Group type: COMPARATOR
Intervention: 500 mg/day griseofulvin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 40
Study: 6609243

Group type: EXPERIMENTAL
Intervention: 3-month exercise-based Cardiac Rehabilitation Program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Routine-care condition
Number of subjects: 48
Study: 30991399

Group type: EXPERIMENTAL
Intervention: OZOILE cream (ozonides with vitamin E acetate)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.1% mometasone furoate (topical corticosteroid)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Untreated foreskin (control group)
Number of subjects: 30
Study: 29156456

Group type: EXPERIMENTAL
Intervention: AUC0-72
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: AUC0-144
Number of subjects: 15
Study: 26819292

Group type: EXPERIMENTAL
Intervention: Freestyle
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Magna Ease
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Trifecta
Number of subjects: 56
Study: 25278098

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - Participants asked to conceal the presence of prohibited items in the backpack.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Group (CG) - Participants not asked to conceal items.
Number of subjects: 0
Study: 22531061

Group type: EXPERIMENTAL
Intervention: Focused-image ultrasonography with vertical vectoring of 15 treatment lines at dual tissue depths
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focused-image ultrasonography with more treatment lines and higher joule energy at dual depths
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focused-image ultrasonography
Number of subjects: 0
Study: 20171776

Group type: EXPERIMENTAL
Intervention: IMSI
Number of subjects: 30

Group type: COMPARATOR
Intervention: ICSI
Number of subjects: 30
Study: 18600434

Group type: EXPERIMENTAL
Intervention: 0.5 g PEG 400
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.75 g PEG 400
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1 g PEG 400
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.25 g PEG 400
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.5 g PEG 400
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0 g PEG 400 (control)
Number of subjects: 12
Study: 16084919

Group type: EXPERIMENTAL
Intervention: Foot bathing at 40 degrees C for 1 hour
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Foot bathing at 41 degrees C for 1 hour
Number of subjects: 6
Study: 12062222

Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 10
Study: 9864074

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for up to 12 weeks (short-term therapy)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for 52 weeks (long-term therapy)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Fluoxetine for 38 weeks, then placebo for 14 weeks (long-term therapy)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Fluoxetine for 14 weeks, then placebo for 38 weeks (long-term therapy)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo for 52 weeks (long-term therapy)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Fluoxetine for 52 weeks (long-term therapy)
Number of subjects: 89
Study: 7634517

Group type: EXPERIMENTAL
Intervention: Tonsillar fossa obliteration using 2/0 Polydioxanone (PDS II) suture
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control side (no intervention)
Number of subjects: 50
Study: 2094589

Group type: COMPARATOR
Intervention: Peptide Plasmodium falciparum sporozoite vaccine conjugated to tetanus toxoid ((NANP)3‐TT) plus placebo (group 1)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Interferon‐alpha (IFN‐alpha) (group 2)
Number of subjects: 37
Study: 359628

Group type: EXPERIMENTAL
Intervention: Codeine 120 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Codeine 60 mg
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 31746327

Group type: EXPERIMENTAL
Intervention: Vitamin D3 400 IU/day
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Vitamin D3 4000 IU/day
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Vitamin D3 10,000 IU/day
Number of subjects: 373

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 373
Study: 29558233

Group type: EXPERIMENTAL
Intervention: Intravenous iron isomaltoside (1200 mg)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Current treatment practice with oral iron
Number of subjects: 85
Study: 28422820

Group type: EXPERIMENTAL
Intervention: VivaSight SL endotracheal tube (ETView group)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard direct laryngoscopy (MAC group)
Number of subjects: 67
Study: 25573027

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) and conventional swallowing therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham electrical stimulation (SES) and conventional swallowing therapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 20
Study: 24516695

Group type: EXPERIMENTAL
Intervention: Flumazenil injection 15 minutes after endoscopy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Flumazenil injection immediately after endoscopy
Number of subjects: 200
Study: 23071074

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) 100% oxygen at 1.5atm
Number of subjects: 49

Group type: COMPARATOR
Intervention: Hyperbaric air (HBA) 14% oxygen at 1.5atm
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Hyperbaric air (HBA)
Number of subjects: 49
Study: 19753607

Group type: EXPERIMENTAL
Intervention: Trichosanthes kirilowii (TK) seed kernels containing 3 g of punicic acid (PA) per day for 28 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sunflower seed kernels (control group)
Number of subjects: 30
Study: 18085913

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Diversified Placement Approach (DPA)
Number of subjects: 187
Study: 15131030

Group type: EXPERIMENTAL
Intervention: TA-CIN (HPV-16 L2/E6/E7 protein)
Number of subjects: 29
Study: 12207145

Group type: EXPERIMENTAL
Intervention: Amisulpride 200-600 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Flupenthixol 5-15 mg/day
Number of subjects: 18
Study: 9062774

Group type: EXPERIMENTAL
Intervention: Timolol treatment
Number of subjects: 0
Study: 7505970

Group type: EXPERIMENTAL
Intervention: Finasteride, a 5-alpha reductase inhibitor, dosage and duration not specified.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0
Study: 3826899

Group type: COMPARATOR
Intervention: Metered-dose inhaler (MDI)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metered-dose inhaler with holding chamber (MDI-HC)
Number of subjects: 12
Study: 30984999

Group type: EXPERIMENTAL
Intervention: Automatic LOR syringe - Epimatic®
Number of subjects: 170

Group type: COMPARATOR
Intervention: Conventional LOR - Perifix®
Number of subjects: 170
Study: 31119905

Group type: EXPERIMENTAL
Intervention: 10-day course of complex decongestive physiotherapy (CDP)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 5-day course of complex decongestive physiotherapy (CDP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Multilayered compression
Number of subjects: 26
Study: 26495784

Group type: EXPERIMENTAL
Intervention: Pancrelipase (72,000 lipase units/meal, 36,000/snack)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 24468407

Group type: EXPERIMENTAL
Intervention: Prismatic adaptation (PA) with a leftward aftereffect administered outside the scanner.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Functional activation in the left anterior insula and left superior frontal gyrus immediately after PA compared to before PA during the time reproduction task.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Functional activation in the left middle frontal gyrus after 30 minutes compared to before PA.
Number of subjects: 17
Study: 21911045

Group type: EXPERIMENTAL
Intervention: Fufangkushen colon-coated capsule (FCC)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Huidi (HD, mesalazine enteric-coated tablets)
Number of subjects: 320
Study: 19819724

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 800 mg oral daily for 20 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 18067816

Group type: EXPERIMENTAL
Intervention: Ulinastatin infusion (6000 U/kg for 30 min, then 1000 U.kg(‐1).h(‐1) until end of operation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal saline infusion (same volume as ulinastatin)
Number of subjects: 24
Study: 16289802

Group type: COMPARATOR
Intervention: Hypnotic suggestions inducing negative emotions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induction of pain-related anger and sadness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestions to increase desire for relief
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestions to decrease desire for relief
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotion-induced changes in pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pain-evoked cardiac responses (R-R interval decrease)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation and multiple regression analyses
Number of subjects: 0
Study: 12930252

Group type: EXPERIMENTAL
Intervention: Earliest atrial activation during tachycardia (ES group, n = 9)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Slow potential during sinus rhythm (SP group, n = 7)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Additional slow potential-guided RFCA in ES group
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Abl/His-CS ratio
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: A/V ratio
Number of subjects: 16
Study: 10973133

Group type: EXPERIMENTAL
Intervention: S. melongena infusion (N = 19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (N = 19)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: S. melongena infusion with dietary orientation (N = 16)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: S. melongena infusion without dietary orientation (N = 38)
Number of subjects: 38
Study: 8826621

Group type: EXPERIMENTAL
Intervention: Nursing information-literacy program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multidimensional evaluation process
Number of subjects: 0
Study: 1400877

Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone enanthate (TE; 100 mg weekly) for 3 months
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo treatment for 3 months
Number of subjects: 13
Study: 3930121

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation
Number of subjects: 92

Group type: COMPARATOR
Intervention: Closed reduction and plaster cast
Number of subjects: 92
Study: 3305794

Group type: EXPERIMENTAL
Intervention: Matched allogenic bone marrow transplantation (BMT) following preparation with cyclophosphamide and fractionated total body irradiation (TBI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Development of acute graft-v-host disease (GVHD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Maintenance chemotherapy with oral methotrexate and mercaptopurine
Number of subjects: 40
Study: 31286929

Group type: EXPERIMENTAL
Intervention: RLPD group
Number of subjects: 47

Group type: COMPARATOR
Intervention: ACL group
Number of subjects: 47
Study: 28173782

Group type: EXPERIMENTAL
Intervention: HealtheSteps™ program
Number of subjects: 110

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 110
Study: 25441591

Group type: EXPERIMENTAL
Intervention: Brown flaxseed (BF)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Golden flaxseed (GF)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (CG) - Wheat bran
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All groups (BF, GF, CG)
Number of subjects: 75
Study: 24118114

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 1711

Group type: COMPARATOR
Intervention: UFH + Abciximab
Number of subjects: 1711
Study: 21458651

Group type: EXPERIMENTAL
Intervention: Implant-assisted mandibular dentures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional mandibular dentures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brachycephalic group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dolichocephalic group
Number of subjects: 0